Showing results (21-30 of 861) with videos related to

Sort By:
Pageof 87
Lifetime Data Analysis|November 16, 2011
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosisPaola Siri, Eric Henninger, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
The quality of reports of randomized trials in multiple sclerosis: a reviewAlessio Signori, Alice Baccino, Maria Pia Sormani
International Journal of MS Care|July 25, 2022
Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future DirectionsBianca Weinstock-Guttman, Maria Pia Sormani, Pavle Repovic
Mutation Research|July 18, 2006
Molecular epidemiology: new rules for new tools?Domenico Franco Merlo, Maria Pia Sormani, Paolo Bruzzi
Neurology|March 10, 2019
How much do periventricular lesions assist in distinguishing migraine with aura from CIS?Caterina Lapucci, Laura Saitta, Giulia Bommarito, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2020
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatmentsAlice Laroni, Irene Schiavetti, Maria Pia Sormani, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Annals of Neurology|September 6, 2013
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisMaria Pia Sormani, Douglas L Arnold, Nicola De Stefano
Neurology|October 2, 2009
A reassessment of the plateauing relationship between T2 lesion load and disability in MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi, et al.
Multiple Sclerosis and Related Disorders|September 22, 2022
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysisAngela Albanese, Maria Pia Sormani, Giovanni Gattorno, et al.
Pageof 87